MSH|^~\&|SendAppName^2.16.840.1.114222.TBD^ISO|Sending-Facility^2.16.840.1.114222.TBD^ISO|PHINCDS^2.16.840.1.114222.4.3.2.10^ISO|PHIN^2.16.840.1.114222^ISO|20140630120030.1234-0500||ORU^R01^ORU_R01|MESSAGE CONTROL ID|D|2.5.1|||||||||NOTF_ORU_v3.0^PHINProfileID^2.16.840.1.114222.4.10.3^ISO~Generic_MMG_V2.0^PHINMsgMapID^2.16.840.1.114222.4.10.4^ISO~TB_MMG_V3.0^PHINMsgMapID^2.16.840.1.114222.4.10.4^ISOPID|1||TB_TC_01^^^SendAppName&2.16.840.1.114222.nnnn&ISO||~^^^^^^S||19780301|M||2028-9^Asian^CDCREC~2106-3^White^CDCREC|^^Atlanta^13^30313^^^^13089^13121009101|||||||||||2186-5^Not Hispanic or Latino^CDCREC||||||||||||||||OBR|1||TB_TC_01^SendAppName^2.16.840.1.114222.TBD^ISO|68991-9^Epidemiologic Information^LN|||20180510111111|||||||||||||||20180810111111|||X||||||10220^Tuberculosis^NNDOBX|1|CWE|78746-5^Country of Birth^LN||CHN^CHINA^ISO3166_1||||||FOBX|2|CWE|77983-5^Country of Usual Residence^LN||USA^UNITED STATES^ISO3166_1||||||FOBX|3|TS|11368-8^Date of Illness Onset^LN||20180115||||||FOBX|4|CWE|77978-5^Subject Died^LN||N^No^HL70136||||||FOBX|5|SN|77998-3^Age at Case Investigation^LN||^40|a^year [time]^UCUM|||||FOBX|6|CWE|77996-7^Pregnancy Status^LN||N^No^HL70136||||||FOBX|7|TS|77975-1^Diagnosis Date^LN||20180202||||||FOBX|8|CWE|77974-4^Hospitalized^LN||N^No^HL70136||||||FOBX|9|ST|74549-7^Person Reporting to CDC - Name^LN||Solo, Han||||||FOBX|10|ST|74547-1^Person Reporting to CDC - Email^LN||hsolo@ga.dph.gov||||||FOBX|11|CWE|77989-2^Transmission Mode^LN||416380006^Airborne transmission^SCT||||||FOBX|12|SN|77991-8^MMWR Week^LN||^17||||||FOBX|13|DT|77992-6^MMWR Year^LN||2018||||||FOBX|14|CWE|77966-0^Reporting State^LN||13^Georgia^FIPS5_2||||||FOBX|15|CWE|77967-8^Reporting County^LN||13089^DeKalb, GA^FIPS6_4||||||FOBX|16|CWE|77968-6^National Reporting Jurisdiction^LN||13^GA^FIPS5_2||||||FOBX|17|CWE|77990-0^Case Class Status Code^LN||PHC178^Not a Case^CDCPHINVS||||||FOBX|18|CWE|77980-1^Case Outbreak Indicator^LN||N^No^HL70136||||||FOBX|19|CWE|48766-0^Reporting Source Type Code^LN||PHC1221^TB Clinic^CDCPHINVS||||||FOBX|20|ST|INV1107^TB State Case Number^PHINQUESTION||2018GA987436179||||||FOBX|21|CWE|DEM153^Detailed Race^PHINQUESTION||2034-7^Chinese^CDCREC||||||FOBX|22|DT|DEM2005^Date Arrived in US^PHINQUESTION||20171107||||||FOBX|23|CWE|DEM2003^US Born^PHINQUESTION||N^No^HL70136||||||FOBX|24|CWE|INV1114^Remain in US After Report^PHINQUESTION||Y^Yes^HL70136||||||FOBX|25|CWE|INV1116^Initial Reason for Evaluation^PHINQUESTION||PHC681^Contact investigation^CDCPHINVS||||||FOBX|26|ST|INV1108^City or County Case Number^PHINQUESTION||2018GAFULT04583||||||FOBX|27|CWE|76689-9^Birth Sex^LN||M^Male^HL70001||||||FOBX|28|CWE|INV1109^Previously Counted Case^PHINQUESTION||PHC659^Verified Case: Counted by another US area^CDCPHINVS||||||FOBX|29|ST|INV1110^Previously Reported State Case Number^PHINQUESTION||2018AL987436179||||||FOBX|30|CWE|INV1112^Inside City Limits^PHINQUESTION||Y^Yes^HL70136||||||FOBX|31|CWE|INV1276^Occupation and Industry Category^PHINQUESTION||UNK^Unknown^NULLFL||||||FOBX|32|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|1|PHC2098^Diabetic at Diagnostic Evaluation^CDCPHINVS||||||FOBX|33|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|1|N^No^HL70136||||||FOBX|34|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|2|46177005^End-Stage Renal Disease^SCT||||||FOBX|35|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|2|N^No^HL70136||||||FOBX|36|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|3|86933000^Heavy Alcohol Use in the Past 12 Months^SCT||||||FOBX|37|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|3|Y^Yes^HL70136||||||FOBX|38|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|4|161663000^Post-Organ Transplantation^SCT||||||FOBX|39|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|4|N^No^HL70136||||||FOBX|40|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|5|32911000^Homeless Ever^SCT||||||FOBX|41|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|5|Y^Yes^HL70136||||||FOBX|42|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|6|PHC1876^Homeless in the Past 12 Months^CDCPHINVS||||||FOBX|43|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|6|Y^Yes^HL70136||||||FOBX|44|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|7|226034001^Injecting Drug Use in the Past 12 Months^SCT||||||FOBX|45|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|7|N^No^HL70136||||||FOBX|46|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|8|PHC1877^Noninjecting Drug Use in the Past 12 Months^CDCPHINVS||||||FOBX|47|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|8|Y^Yes^HL70136||||||FOBX|48|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|9|42665001^Resident of Long-Term Care Facility at Diagnositic Evaluation^SCT||||||FOBX|49|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|9|UNK^Unknown^NULLFL||||||FOBX|50|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|10|OTH^Other (specify)^NULLFL^^^^^^cancer||||||FOBX|51|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|10|Y^Yes^HL70136||||||FOBX|52|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|11|PHC1878^Other Immunocompromise (not HIV/AIDS)^CDCPHINVS||||||FOBX|53|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|11|N^No^HL70136||||||FOBX|54|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|12|257656006^Resident of Correctional Facility at Diagnostic Evaluation^SCT||||||FOBX|55|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|12|N^No^HL70136||||||FOBX|56|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|13|PHC2099^Resident of Correctional Facility Ever^CDCPHINVS||||||FOBX|57|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|13|N^No^HL70136||||||FOBX|58|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|14|PHC690^TNF Antagonist Therapy^CDCPHINVS||||||FOBX|59|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|14|N^No^HL70136||||||FOBX|60|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|15|3738000^Viral hepatitis (any type)^SCT||||||FOBX|61|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|15|UNK^Unknown^NULLFL||||||FOBX|62|CWE|72166-2^Smoking Status^LN||449868002^Current every day smoker^SCT||||||FOBX|63|CWE|INV1121^Patient lived outside of US for more than 2 months^PHINQUESTION||Y^Yes^HL70136||||||FOBX|64|CWE|INV290^Test Type^PHINQUESTION|16|20431-3^Smear^LN||||||FOBX|65|CWE|INV291^Test Result^PHINQUESTION|16|10828004^Positive^SCT||||||FOBX|66|TS|82773-3^Date/Time of Lab Result^LN|16|20180205||||||FOBX|67|CWE|31208-2^Specimen Source Site^LN|16|119334006^sputum^SCT||||||FOBX|68|TS|68963-8^Specimen Collection Date/Time^LN|16|20180202||||||FOBX|69|CWE|INV290^Test Type^PHINQUESTION|17|50941-4^Culture^LN||||||FOBX|70|CWE|INV291^Test Result^PHINQUESTION|17|260385009^Negative^SCT||||||FOBX|71|TS|82773-3^Date/Time of Lab Result^LN|17|20180314||||||FOBX|72|CWE|31208-2^Specimen Source Site^LN|17|119334006^sputum^SCT||||||FOBX|73|TS|68963-8^Specimen Collection Date/Time^LN|17|20180202||||||FOBX|74|CWE|INV290^Test Type^PHINQUESTION|18|LAB673^NAA^PHINQUESTION||||||FOBX|75|CWE|INV291^Test Result^PHINQUESTION|18|385660001^Not Done^SCT||||||FOBX|76|CWE|INV290^Test Type^PHINQUESTION|19|LAB671^IGRA-QFT^PHINQUESTION||||||FOBX|77|CWE|INV291^Test Result^PHINQUESTION|19|10828004^Positive^SCT||||||FOBX|78|TS|82773-3^Date/Time of Lab Result^LN|19|20180203||||||FOBX|79|TS|68963-8^Specimen Collection Date/Time^LN|19|20180202||||||FOBX|80|CWE|INV290^Test Type^PHINQUESTION|20|55277-8^HIV Status^LN||||||FOBX|81|CWE|INV291^Test Result^PHINQUESTION|20|10828004^Positive^SCT||||||FOBX|82|TS|82773-3^Date/Time of Lab Result^LN|20|20180210||||||FOBX|83|CWE|31208-2^Specimen Source Site^LN|20|87612001^Blood^SCT||||||FOBX|84|TS|68963-8^Specimen Collection Date/Time^LN|20|20180204||||||FOBX|85|CWE|INV290^Test Type^PHINQUESTION|21|TB119^Tuberculin Skin Test^PHINQUESTION||||||FOBX|86|CWE|INV291^Test Result^PHINQUESTION|21|385660001^Not Done^SCT||||||FOBX|87|CWE|INV290^Test Type^PHINQUESTION|22|76629-5^Fasting blood glucose^LN||||||FOBX|88|CWE|INV291^Test Result^PHINQUESTION|22|385660001^Not Done^SCT||||||FOBX|89|CWE|INV290^Test Type^PHINQUESTION|23|50595-8^Pathology^LN||||||FOBX|90|CWE|INV291^Test Result^PHINQUESTION|23|385660001^Not Done^SCT||||||FOBX|91|CWE|LAB677^Type of Chest Study^PHINQUESTION|24|399208008^Plain Chest X-Ray^SCT||||||FOBX|92|CWE|LAB678^Result of Chest Study^PHINQUESTION|24|PHC1873^Consistent with TB^CDCPHINVS||||||FOBX|93|CWE|LAB679^Evidence of Cavity^PHINQUESTION|24|N^No^HL70136||||||FOBX|94|CWE|LAB680^Evidence of Miliary TB^PHINQUESTION|24|Y^Yes^HL70136||||||FOBX|95|TS|LAB681^Date of Chest Study^PHINQUESTION|24|20180201||||||FOBX|96|CWE|LAB677^Type of Chest Study^PHINQUESTION|25|169069000^CT Scan^SCT||||||FOBX|97|CWE|LAB678^Result of Chest Study^PHINQUESTION|25|385660001^Not Done^SCT||||||FOBX|98|CWE|INV1274^Case Meets Binational Reporting Criteria^PHINQUESTION||N^No^HL70136||||||FOBX|99|CWE|INV1122^Identified During Contact Investigation^PHINQUESTION||Y^Yes^HL70136||||||FOBX|100|CWE|INV1123^Evaluation During Contact Investigation^PHINQUESTION||Y^Yes^HL70136||||||FOBX|101|ST|INV1124^Linked Case Number^PHINQUESTION||2018GA287163402||||||FOBX|102|DT|86948-7^Date Treatment or Therapy Started^PHINQUESTION||20180210||||||FOBX|103|CWE|55753-8^Treatment Administration Type^LN||435891000124101^DOT (Directly observed therapy, in person)^SCT~PHC1881^EDOT (Electronic DOT, via video call or other electronic method)^CDCPHINVS||||||FOBX|104|CWE|INV1115^Case Verification Category^PHINQUESTION||PHC654^3 - Clinical Case Definition^CDCPHINVS||||||FOBX|105|CWE|TB101^Status at Diagnosis of TB^PHINQUESTION||438949009^Alive^SCT||||||FOBX|106|CWE|INV1133^Site of Disease^PHINQUESTION||39607008^Lung structure^SCT||||||FOBX|107|CWE|INV1134^Contact Investigation^PHINQUESTION||Y^Yes^HL70136||||||FOBX|108|CWE|161413004^History of Previous Illness^SCT||Y^Yes^HL70136||||||FOBX|109|CWE|INV1135^Diagnosis Type^PHINQUESTION|26|11999007^LTBI^SCT||||||FOBX|110|DT|82758-4^Date of Previous Illness^LN|26|201504||||||FOBX|111|CWE|INV1137^Completed Treatment for Previous Diagnosis^PHINQUESTION|26|Y^Yes^HL70136||||||FOBX|112|CWE|INV1139^Reason Not Treated with RIPE^PHINQUESTION||PHC1909^Suspected Drug Resistance^CDCPHINVS||||||FOBX|113|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|27|641^Amikacin^RXNORM||||||FOBX|114|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|27|N^No^HL70136||||||FOBX|115|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|28|7833^Para-Aminesalicylicacid^RXNORM||||||FOBX|116|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|28|N^No^HL70136||||||FOBX|117|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|29|1364504^Bedaquiline^RXNORM||||||FOBX|118|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|29|Y^Yes^HL70136||||||FOBX|119|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|30|78903^Capreomycin^RXNORM||||||FOBX|120|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|30|N^No^HL70136||||||FOBX|121|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|31|2551^Ciprofloxacin^RXNORM||||||FOBX|122|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|31|Y^Yes^HL70136||||||FOBX|123|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|32|2592^Clofazimine^RXNORM||||||FOBX|124|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|32|N^No^HL70136||||||FOBX|125|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|33|3007^Cycloserine^RXNORM||||||FOBX|126|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|33|N^No^HL70136||||||FOBX|127|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|34|PHC1889^Delamanid^CDCPHINVS||||||FOBX|128|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|34|N^No^HL70136||||||FOBX|129|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|35|4110^Ethambutol^RXNORM||||||FOBX|130|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|35|Y^Yes^HL70136||||||FOBX|131|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|36|4127^Ethionamide^RXNORM||||||FOBX|132|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|36|N^No^HL70136||||||FOBX|133|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|37|6038^Isoniazid^RXNORM||||||FOBX|134|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|37|Y^Yes^HL70136||||||FOBX|135|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|38|6099^Kanamycin^RXNORM||||||FOBX|136|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|38|UNK^Unknown^NULLFL||||||FOBX|137|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|39|82122^Levofloxacin^RXNORM||||||FOBX|138|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|39|Y^Yes^HL70136||||||FOBX|139|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|40|190376^Linezolid^RXNORM||||||FOBX|140|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|40|UNK^Unknown^NULLFL||||||FOBX|141|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|41|139462^Moxifloxacin^RXNORM||||||FOBX|142|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|41|N^No^HL70136||||||FOBX|143|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|42|7623^Ofloxacin^RXNORM||||||FOBX|144|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|42|N^No^HL70136||||||FOBX|145|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|43|OTH^Other (specify)^NULLFL||||||FOBX|146|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|43|N^No^HL70136||||||FOBX|147|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|44|PHC1888^Other Quinolones^CDCPHINVS||||||FOBX|148|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|44|N^No^HL70136||||||FOBX|149|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|45|8987^Pyrazinamide^RXNORM||||||FOBX|150|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|45|Y^Yes^HL70136||||||FOBX|151|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|46|55672^Rifabutin^RXNORM||||||FOBX|152|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|46|N^No^HL70136||||||FOBX|153|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|47|9384^Rifampin^RXNORM||||||FOBX|154|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|47|N^No^HL70136||||||FOBX|155|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|48|35617^Rifapentine^RXNORM||||||FOBX|156|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|48|N^No^HL70136||||||FOBX|157|CWE|INV1143^Initial Drug Regimen^PHINQUESTION|49|10109^Streptomycin^RXNORM||||||FOBX|158|CWE|INV1144^Initial Drug Regimen Indicator^PHINQUESTION|49|N^No^HL70136||||||FOBX|159|CWE|INV1145^Isolate Submitted for Genotyping^PHINQUESTION||N^No^HL70136||||||FOBX|160|CWE|INV1147^Phenotypic Drug Susceptibility Completed^PHINQUESTION||N^No^HL70136||||||FOBX|161|CWE|INV1148^Molecular Drug Susceptibility Completed^PHINQUESTION||N^No^HL70136||||||FOBX|162|CWE|INV1275^Patient Treated as MDR Case^PHINQUESTION||N^No^HL70136||||||FOBX|163|CWE|TB279^Patient Move During TB Therapy^PHINQUESTION||Y^Yes^HL70136||||||FOBX|164|CWE|INV1152^Moved to Where^PHINQUESTION||PHC246^Out of State^CDCPHINVS||||||FOBX|165|CWE|INV1153^Out of State Move^PHINQUESTION||01^Alabama^FIPS5_2||||||F